Polyneuropathy and Hospitalisation

Summary:

Hospitalisation is found among people with Polyneuropathy, especially for people who are female, 60+ old.

The study analyzes which people have Hospitalisation with Polyneuropathy. It is created by eHealthMe based on reports of 15 people who have Polyneuropathy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Polyneuropathy?

Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously) is found to be associated with 911 drugs and 944 conditions by eHealthMe. Check the latest studies of Polyneuropathy.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,715 drugs and 1,133 conditions by eHealthMe. Check the latest studies of Hospitalisation.



On Jul, 24, 2026

15 people who have Polyneuropathy and Hospitalisation are studied.

Would you have Hospitalisation when you have Polyneuropathy?

Gender of people who have Polyneuropathy and experienced Hospitalisation *:

  • female: 78.57 %
  • male: 21.43 %

Age of people who have Polyneuropathy and experienced Hospitalisation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 75 %

Common co-existing conditions for these people *:

  1. Osteoporosis (bones weak and more likely to break): 3 people, 20.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 20.00%
  3. Immunodeficiency Common Variable: 3 people, 20.00%
  4. Sinusitis (inflammation of sinus): 1 person, 6.67%
  5. Rickets (softening of bones): 1 person, 6.67%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
  7. Pemphigoid (tense blisters on the skin): 1 person, 6.67%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.67%
  9. Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 1 person, 6.67%
  10. Headache (pain in head): 1 person, 6.67%

Common drugs taken by these people *:

  1. Crestor: 4 people, 26.67%
  2. Norco: 4 people, 26.67%
  3. Acetaminophen: 3 people, 20.00%
  4. Lyrica: 3 people, 20.00%
  5. Oxycontin: 3 people, 20.00%
  6. Synthroid: 3 people, 20.00%
  7. Biotin: 3 people, 20.00%
  8. Vitamin B12: 3 people, 20.00%
  9. Vitamin D3: 3 people, 20.00%
  10. Premarin: 3 people, 20.00%

Common symptoms for these people *:

  1. Oedema (fluid collection in tissue): 4 people, 26.67%
  2. Fatigue (feeling of tiredness): 4 people, 26.67%
  3. Migraine (headache): 3 people, 20.00%
  4. Dehydration (dryness resulting from the removal of water): 3 people, 20.00%
  5. Hip Fracture: 3 people, 20.00%
  6. Urinary Tract Infection: 3 people, 20.00%
  7. Pain: 3 people, 20.00%
  8. Fall: 3 people, 20.00%
  9. Furuncle (infection of the hair follicle): 3 people, 20.00%
  10. Drug Dependence: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hospitalisation:

All the conditions that are associated with Hospitalisation:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hospitalisation and Polyneuropathy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: